Cell Line Development Market by Product 2025 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cell Line Development Market
Cell Line Development Market: By Product (Equipment, Media and Reagents), By Source (mammalian, insect), By Type (Primary cells, Hybridomass), By Application (Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) & By Region - Forecast (2017- 2022)
Report Code : HCR 0434
Updated Date: 13 March, 2017  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Cell Line Development Market – Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Cell Line Development Market– Forces
   4.1. Drivers
      4.1.1. Technological advancement in pharmaceutical industry
      4.1.2. Rising vaccine production
   4.2. Restraints
      4.2.1. High capital requirement
      4.2.2. Development of stable and authenticate cell line
   4.3. Opportunities
      4.3.1. Increasing Risk of Pandemics and Communicable Diseases 
      4.3.2. Low Income Countries to Create Opportunities for the Cell Line Market
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Cell Line Development Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life cycle Analysis
   5.5. Suppliers & Distributors
6. Cell Line Development Market, By Product
   6.1. Cell Line Development Market, Products
      6.1.1. Biosafety Cabinets 
      6.1.2. Cell Counters & Viability Analysis Systems 
      6.1.3. Incubators 
      6.1.4. Centrifuges 
      6.1.5. Bioreactors 
      6.1.6. Storage Equipment
      6.1.7. Automation Systems 
      6.1.8. Microscopes 
      6.1.9. Filtration Systems 
      6.1.10. Other Equipment
   6.2. Cell Line Development Market, Media & Reagents
      6.2.1. Sera
      6.2.2. Media
      6.2.3. Reagents
7. Cell Line Development Market, By Source
   7.1. Mammalian 
   7.2. Insect 
   7.3. Amphibian
8. Cell Line Development Market, By Type
   8.1. Primary Cell Lines 
   8.2. Continuous Cell Lines 
   8.3. Hybridomas 
   8.4. Recombinant Cell Lines
9. Cell Line Development Market, By Application
   9.1. Bioproduction
   9.2. Tissue Engineering & Regenerative Medicine 
   9.3. Toxicity Testing 
   9.4. Research 
   9.5. Drug Discovery
10. Cell Line Development Market, By Geography
   10.1. Europe
      10.1.1. Germany
      10.1.2. France
      10.1.3. Italy
      10.1.4. Spain
      10.1.5. Russia
      10.1.6. U.K.
      10.1.7. Rest of Europe
   10.2. Asia Pacific
      10.2.1. China
      10.2.2. India
      10.2.3. Japan
      10.2.4. South Korea
      10.2.5. Rest of Asia-Pacific
   10.3. North America 
      10.3.1. U.S.
      10.3.2. Canada
      10.3.3. Mexico
   10.4. Rest of the World (RoW)
      10.4.1. Middle East
      10.4.2. South America
      10.4.3. Africa
11. Cell Line Development – Market Entropy
   11.1. Expansion
   11.2. Technological Developments
   11.3. Merger & Acquisitions, and Joint Ventures
   11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. American Type Culture Collection (ATCC) 
   12.2. Corning, Inc. 
   12.3. European Collection of Cell Cultures (ECACC) 
   12.4. GE Healthcare 
   12.5. Lonza Group AG 
   12.6. Sartorius AG 
   12.7. Selexis SA 
   12.8. Sigma-Aldrich Corporation 
   12.9. Thermo Fisher Scientific, Inc. 
   12.10. Wuxi Apptec 
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibiliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Cell line construction or Cell line development acts as a key factor in reducing the production costs of biopharmaceuticals while producing a high yield of product. Development and selection of cell lines compatible with production requirements can lead to significant time savings at later stages of biopharmaceuticals production. Rapid growth and technological advancement in pharmaceutical industry is expected to remain key growth driver for cell line development market during the period of study. 

This report identifies the global cell line development market size in for the year 2015-2017, and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global cell line development market.

Cell Line Development Market

Geographically North America dominated the global cell line development market owing to technological advancement, higher investment in R&D activities by healthcare and pharmaceutical industry. North America was followed by Europe and Asia-Pacific as the second and third largest markets for cell line development. However Asia-Pacific is expected to remain the fastest growing market during the period of study driven by rapidly expanding and increasing presence of global pharmaceutical and healthcare giants in the major economies such as India and China in the region. 

This report segments global cell line development market on the basis of product, source, type, application, end user and regional market as follows:
  • On the basis of products this report on global cell line development market is segmented as follows, covering all major products in the cell line development as follows: Products, Media, Reagents and Sera 
  • This report on global cell line development also covers in detail various sources of cell line development, some of the major sources covered in the report are mammalian, amphibian and insect
  • This report on global cell line development also covers in detail types of cell line development, some of the major types covered in the report are cloud based, Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines
  • This report on global cell line development also covers in detail various applications of cell line development, some of the major applications covered in the report are bioproduction, Tissue Engineering & Regenerative Medicine, toxicity Testing, Research, Drug Discovery
  • This report on cell line development has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region

Sample Companies Profiled in this Report are:
  • GE Healthcare (Division of General Electric Company) 
  • American Type Culture Collection (ATCC) 
  • Corning, Inc. 
  • European Collection of Cell Cultures (ECACC) 
  • Lonza Group AG
  • 30+.
List of Tables:

Table 1: Cell Line Development Market Key Companies, 2016
Table 2: Global Cell Line Development Market, Competitor Benchmarking
Table 3: Global Cell Line Development Products Market Revenue, By Product Type, 2016-2024 ($Million)
Table 4: Global Cell Line Development Market Revenue, By Source, 2016-2024 ($Million)
Table 5: Global Cell Line Development Market Revenue, By Type, 2016-2024 ($Million)
Table 6: Cell Line Development Market Revenue, By Application, 2016-2024 ($Million)
Table 7: Cell Line Development Market Value, By Geography, 2016-2024($Million)
Table 8: Europe: Cell Line Development  Products Market Value, By Product, 2016-2024 ($Million) 
Table 9: Europe: Cell Line Development Market Value, By Source, 2016-2024 ($Million) 
Table 10: Europe: Cell Line Development Market Value, By Type, 2016-2024 ($Million) 
Table 11: Europe: Cell Line Development Market Value, By Application, 2016-2024 ($Million) 
Table 12: Europe: Cell Line Development Market Value, By Country, 2016-2024 ($Million) 
Table 13: Germany: GDP – Composition of 2015, By End Use
Table 14: France: GDP – Composition of 2015, By End Use
Table 15: U.K.: GDP – Composition of 2015, By End Use
Table 16: APAC Cell Line Development Products Market Revenue, By Product, 2016-2024 ($Million)
Table 17: APAC Cell Line Development Market Revenue, By Source, 2016-2024 ($Million) 
Table 18: APAC Cell Line Development Market Revenue, By Type 2016-2024 ($Million)
Table 19: APAC Cell Line Development Market Revenue, By Application, 2016-2024 ($Million) 
Table 20: APAC Cell Line Development Market Revenue, By Geography 2016-2024 ($Million)
Table 21: China: GDP – Composition of 2015, By End Use
Table 22: Japan: GDP – Composition of 2015, By End Use
Table 23: India: GDP – Composition of 2015, By End Use
Table 24: North  America: Cell Line Development Products Market Value, By Product,  2016-2024 ($Million)
Table 25: North  America: Cell Line Development Market Value, By Source,  2016-2024 ($Million)
Table 26: North  America: Cell Line Development Market Value, By Type,  2016-2024 ($Million)
Table 27: North  America: Cell Line Development Market Value, By Application,  2016-2024 ($Million)
Table 28: North  America: Cell Line Development Market Value, By Country,  2016-2024 ($Million)
Table 29: U.S.: GDP – Composition of 2015, By End Use
Table 30: Canada : GDP – Composition of 2015, By End Use
Table 31: Mexico: GDP – Composition of 2015, By End Use
Table 32: ROW: Cell Line Development Products Market Revenue, By Product, 2016-2024 ($Million)
Table 33: ROW: Cell Line Development Market Revenue, By Source, 2016-2024 ($Million) 
Table 34: ROW: Cell Line Development Market Revenue, By Type, 2016-2024 ($Million)
Table 35: ROW: Cell Line Development Market Revenue, By Application, 2016-2024 ($Million) 
Table 36: ROW: Cell Line Development Market Revenue, By Geography, 2016-2024 ($Million)
Table 37: Cell Line Development Market: Product Portfolio



List of Figures:

Figure 1: Cell Line Development Market Revenue, 2016-2024 ($Million) 
Figure 2: Cell Line Development Products Market Value, By Product Type, 2016, 2024, ($Million)
Figure 3: Cell Line Development Market Value, By Source, 2016, 2024, ($Million)
Figure 4: Cell Line Development Market Value, By Type, 2016, 2024, ($Million)
Figure 5: Cell Line Development Market Value, By Application, 2016, 2024, ($Million)
Figure 6: Cell Line Development Market Share, By Region, 2016, 2024(%)
Figure 7: Cell Line Development Patents, By Year, 2013-2017
Figure 8: Cell Line Development Patents Share, By Applicant (%)
Figure 9: Cell Line Development Patents Share, By Geography (%)
Figure 10: Lonza Group
Figure 11: Catalent, Inc
Figure 12: Merck KGaA
Figure 13: EPS, By Company, ($)
Figure 14: Global Cell Line Development Market Lifecycle
Figure 15: Equipment: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 16: Biosafety Cabinets: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 17: Cell Counters & Viability Analysis Systems: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 18: Incubators: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 19: Centrifuges: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 20: Bioreactors: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 21: Storage Equipment: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 22: Automation Systems: Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 23: Microscopes: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 24: Filtration Systems: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 25: Other Equipment: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 26: Media & Reagents: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 27: Sera: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 28: Media: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 29: Reagents: Global Cell Line Development Products Market Revenue, 2016-2024 ($Million)
Figure 30: Mammalian: Global Cell Line Development  Market Revenue, 2016-2024 ($Million)
Figure 31: Insect: Global Cell Line Development  Market Revenue, 2016-2024 ($Million)
Figure 32: Amphibian: Global Cell Line Development  Market Revenue, 2016-2024 ($Million)
Figure 33: Primary Cell Lines: Global Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 34: Continuous Cell Lines: Global Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 35: Hybridomas: Global Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 36: Recombinant Cell Lines: Global Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 37: Bioproduction: Cell Line Development Market, By Application, 2016-2024, ($Million)
Figure 38: Tissue Engineering & Regenerative Medicine: Cell Line Development Market, By Application, 2016-2024, ($Million)
Figure 39: Toxicity Texting: Cell Line Development Market, By Application, 2016-2024, ($Million)
Figure 40: Research: Cell Line Development Market, By Application, 2016-2024, ($Million)
Figure 41: Drug Discovery: Cell Line Development Market, By Application, 2016-2024, ($Million)
Figure 42: Germany: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 43: Germany: GDP – Composition of 2015, By Sector of Origin
Figure 44: Germany: Export and Import Value, 2012-2015 ($Billion)
Figure 45: France: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 46: France: GDP – Composition of 2015, By Sector of Origin
Figure 47: France: Export and Import Value, 2012-2015 ($Billion)
Figure 48: U.K.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 49: U.K.: GDP – Composition of 2015, By Sector of Origin
Figure 50: U.K.: Export and Import Value, 2012-2015 ($Billion)
Figure 51: U.K. : Cell Line Development Market Value, 2016-2024 ($Million)
Figure 52: Italy: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 53: Germany: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 54: France: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 55: Spain: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 56: Russia: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 57: Rest of Europe Cell Line Development Market Value, 2016-2024 ($Million)
Figure 58: Europe: Cell Line Development Market CAGR, By Countries 2018-2024 (%)
Figure 59: China: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 60: China: GDP – Composition of 2015, By Sector of Origin
Figure 61: China: Export and Import Value, 2012-2015 ($Million)
Figure 62: Japan: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 63: Japan: GDP – Composition of 2015, By Sector of Origin
Figure 64: Japan: Export and Import Value, 2012-2015 ($Billion)
Figure 65: India: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 66: India: GDP – Composition of 2015, By Sector of Origin
Figure 67: India: Export and Import Value, 2012-2015 ($Million)
Figure 68: Rest of APAC: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 69: China: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 70: Japan: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 71: India: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 72: South Korea: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 73: APAC: Cell Line Development Market CAGR, By Countries, 2016-2024 (%)
Figure 74: U.S.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 75: U.S.: GDP – Composition of 2015, By Sector of Origin
Figure 76: U.S.: Export and Import Value, 2012-2015 ($Trillion)
Figure 77: Canada: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 78: Canada: GDP – Composition of 2015, By Sector of Origin
Figure 79: Canada : Export and Import Value, 2012-2015 ($Billion)
Figure 80: Mexico: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 81: Mexico: GDP – Composition of 2015, By Sector of Origin
Figure 82: Mexico: Export and Import Value, 2012-2015 ($Billion)
Figure 83: U.S. : Cell Line Development Market Value, 2016-2024 ($Million)
Figure 84: Mexico: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 85: Canada: Cell Line Development Market Value, 2016-2024 ($Million)
Figure 86: North America: Cell Line Development Market CAGR, By Countries, 2018-2024 (%)
Figure 87: South America: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 88: Middle East: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 89: Africa: Cell Line Development Market Revenue, 2016-2024 ($Million)
Figure 90: ROW: Cell Line Development Market CAGR, By Regions, 2016-2024 (%)
Figure 91: Cell Line Development Market Entropy Share, (%) By Approaches (2013-2018*)
Figure 92: Cell Line Development: Total Developments, By Year 2@013-2018*
Figure 93: Cell Line Development: Total Number of Developments, By Companies,  2013-2018*
Figure 94: Corning Incorporated, Revenue ($Billion), 2014-2017
Figure 95: Corning Incorporated, Revenue Share (%), By Business Segments, 2017
Figure 96: Corning Incorporated, Revenue Share (%), By Geography, 2017
Figure 97: General Electric Company, Revenue ($Billion), 2014-2017
Figure 98: General Electric Company, Revenue Share (%), By Business Segments, 2017
Figure 99: General Electric Company, Revenue Share (%), By Geography, 2017
Figure 100: Lonza, Revenue ($Billion), 2014-2017
Figure 101: Lonza, Revenue Share (%), By Business Segments, 2017
Figure 102: Lonza, Revenue Share (%), By Geography, 2017
Figure 103: Sartorius AG, Revenue ($Billion), 2014-2017
Figure 104: Sartorius AG, Revenue Share (%), By Business Segments, 2017
Figure 105: Sartorius AG, Revenue Share (%), By Geography, 2017
Figure 106: Merck KGaA, Revenue ($Million), 2013-2016
Figure 107: Merck KGaA, Revenue Share (%), By Business Segments, 2017
Figure 108: Merck KGaA, Revenue Share (%), By Geography, 2017
Figure 109: Thermo Fisher Scientific Inc, Revenue ($Million), 2013-2016
Figure 110: Thermo Fisher Scientific Inc, Revenue Share (%), By Business Segments, 2017
Figure 111: Thermo Fisher Scientific Inc, Revenue Share (%), By Geography, 2017
Figure 112: JSR Corporation, Revenue ($Billion), 2013-2016
Figure 113: JSR Corporation, Revenue Share (%), By Geography, 2017
Figure 114: JSR Corporation, Revenue Share (%), By Business Segments,  2017
Figure 115: Danaher, Revenue ($Billion), 2014-2017
Figure 116: Danaher, Revenue Share (%), By Business Segments, 2017
Figure 117: Danaher, Revenue Share (%), By Geography, 2017
Figure 118: Samsung Biologics, Revenue ($Billion), 2015-2017
Figure 119: Samsung Biologics, Revenue Share (%), By Business Segments, 2017
Figure 120: Catalent, Inc, Revenue ($Billion), 2014-2017
Figure 121: Catalent, Inc, Revenue Share (%), By Business Segments, 2017
Figure 122: Catalent, Inc, Revenue Share (%), By Geography, 2017
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll